Editorial Staff

  • Executive Editor/VP-Special Projects:
    Jeff Hall
  • Senior Editor
    Brian McCurdy
  • Circulation and Subscriptions
    Bonnie Shannon
  • Art Director:
    Alana Balboni
  • Editorial Correspondence

  • Jeff Hall, Executive Editor/VP-Special Projects, Podiatry Today
  • HMP Communications, 83 General Warren Blvd
    Suite 100, Malvern PA 19355
  • Telephone: (800) 237-7285, ext. 214
    Fax: (610) 560-0501
  • Email: jhall@hmpcommunications.com
  • November 2003 | Volume 16 - Issue 11
    By John Hester, DPM, PT
    11,859 reads | 0 comments | 11/03/03
    Clinical Editor: Lawrence Karlock, DPM
    10,452 reads | 0 comments | 11/03/03
    Ischemic wounds can be challenging for any physician. With this in mind, the panelists discuss key indicators to look for in the history and physical exam, the effectiveness of noninvasive vascular testing and parameters for performing an amputation after bypass surgery. They also explore the treatment possibilities of angioplasty/stenting and the long leg distal bypass. Without further delay, here is what they had to say. Q: What is your workup/treatment plan when a new patient presents with an ischemic foot wound? A: Mark Beylin, DPM, says it starts by determining the patient’s ... continue reading
    By John Mozena, DPM
    14,136 reads | 0 comments | 11/03/03
    Plantar fasciitis is certainly one of the most common conditions we see in podiatric practice and more than 90 percent of patients are cured with conservative treatment.1 It sounds relatively simple. Well, in order to consistently facilitate successful outcomes, not only must one have a strong anatomical understanding of the plantar fascia, there must also be a strong command of the various causes of the condition, key diagnostic indicators and when to apply various treatment solutions in the armamentarium. ... continue reading
    By Leon Brill, DPM, CWS
    8,410 reads | 0 comments | 11/03/03
    The research of the ‘70s and ‘80s seems to have paid off in the array of high-tech bioactive wound care products and innovative dressings that have emerged on the market in recent years. We have seen new and improved hydrogels, alginates, growth factors, living skin equivalents and vacuum assisted closure, not to mention new classes of antibiotics to cover emergent drug resistant organisms and modifications of existing antibiotic classes to increase the spectrum of activity. Did I mention silver ion dressings and combination dressings? We have been given an armamentarium unlike we hav ... continue reading
    By Jeff Hall, Editor-in-Chief
    2,447 reads | 0 comments | 11/03/03
    When it comes to multicenter clinical trials for various wound care modalities, it stands to reason all the elements of the study should be constant with the key variable being the modality or modalities one is comparing in order to determine the efficacy. However, what if one of those study elements (say offloading) is handled differently by the researchers involved in the study? Wouldn’t that detract from the validity of the results? It’s a significant question raised in a recent Diabetes Care editorial, “Trials In Neuropathic Diabetic Foot Ulceration,” penned by David Arm ... continue reading